Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

doi:10.1016/S1473-3099(19)30310-X

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Decision Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1001-1012
Number of pages	12
Journal	The Lancet Infectious Diseases
Volume	19
Issue number	9
DOIs	https://doi.org/10.1016/S1473-3099(19)30310-X
Publication status	Published - Sept 2019

ASJC Scopus Subject Areas

Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1473-3099(19)30310-X

Cite this

@article{99223f6992844d69813d3dc9042864ca,

title = "Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial",

author = "McNeil, {Shelly A.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = sep,

doi = "10.1016/S1473-3099(19)30310-X",

language = "English",

volume = "19",

pages = "1001--1012",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies

T2 - a two-arm, randomised, double-blind, phase 3 trial

AU - McNeil, Shelly A.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85071372218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071372218&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(19)30310-X

DO - 10.1016/S1473-3099(19)30310-X

M3 - Article

C2 - 31399378

AN - SCOPUS:85071372218

SN - 1473-3099

VL - 19

SP - 1001

EP - 1012

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 9

ER -

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this